Strados Labs - Cough Trial Solution
Beyond Cough Count: RESP Cough Trial Solution (CTS) optimizes chronic cough trials to better capture lung sound biomarkers. RESP allows clinical endpoints for coughs to be captured and show positive results. A portion of these positive results revolve around being able to differentiate between voluntary coughs vs. involuntary coughs to determining if the drug is working as planned. RESP makes that possible.
-
Most popular related searches
Cough Monitoring Comparison
WHY CHOOSE RESP?
Common Cough Monitoring Challenges
- Incomplete Recordings (subjects or sites removed early in error)
- Typically limited to cough count frequency only
- Lag time from screening assessment to deployment of device to randomize subjects
RESP Solution
- Allows for identification of coughing and other adventitious breath sounds such as wheeze, rales and rhonchi
- Ability to differentiate cough types in addition to frequency (e.g., productive, dry cough, spasms, etc.)
- Small form factor and simple adhesive application to chest wall
A respiratory tool bringing the trial to the patient
Strados Labs RESP fits perfectly into decentralized trials allowing remote patient access by unlocking lung sound data and putting it into the hands of the entire research team via the cloud. RESP makes decentralized respiratory trials scalable and able to develop entirely new insights about respiratory status without episodic patient interaction.
Wireless biosensor for DCT
- Patient-centric
- Telemedecine workflow integration
- Real-time lung data access
Respiratory trial success hinges on the ability to obtain more clinically accurate symptoms records. This can be achieved at a low-cost and scaled across researcher centers–reducing variability in reports and providing entirely new insights about respiratory status in connection with devices and drugs.
Seamlessly Capture Lung Sounds and Clinical Data Points
The life sciences industry benefits from the enhancement of pulmonary care monitoring capabilities the RESP Smart Sensor Platform provides–gaining insight into patient drug response by analysis of longitudinal lung acoustics.
- 1,000,000 clinically validated pulmonary data points
- FDA-cleared
- CE Mark Approved
Patient Privacy & Security
Noise cancellation is applied to enhance the signal to noise ratio and eliminate speech discernibility while being HIPAA compliant with an end-to-end encryption.
Real-Time Data Analysis
Data collected is uploaded automatically to the Strados Cloud to allow for timely assessment of recordings with identification of adventitious breath sounds including respiratory dynamics with machine learning algorithms.
Patient Centricity
Wireless, non-invasive biosensor that monitors, records and stores every lung sound. That translates into longer wear times and an astounding 99.59% patient compliance.
Longitudinal Lung Data
Identification of wheeze, cough and CABS detection gives the objective measurement of these changes over time on a patient and population basis with an ability to differentiate cough types in addition to frequency.
Data Collection Capacity
220 hours of continuous data collection without patient intervention of objective lung sounds and respiratory dynamics while having access to data for post-processing and analysis.
Customer reviews
No reviews were found for Strados Labs - Cough Trial Solution. Be the first to review!